A randomized controlled trial of pentoxifylline for the prevention of delayed graft function in cadaveric kidney graft

Clinical Transplantation

Volumn 11, Issue 3, 1997, Pages 169-173

  Noël, Christian ^a,b   Hazzan, Marc ^a   Coppin, Marie Christine ^a   Codaccioni, Marie Xavière ^a   Pruvot, François René ^a   Labalette, Myriam ^a   Lelièvre, Gaston ^a  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cyclosporine toxicity; Delay graft function; Ischemia reperfusion; Renal transplantation; TNF

Indexed keywords

CYCLOSPORIN; PENTOXIFYLLINE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CADAVER KIDNEY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; LEUKOCYTE ACTIVATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR DISEASE;

EID: 0030997846     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. ERNSTER L. Biochemistry of reoxygenation injury. Crit Care Med 1988: 16: 947.
2. DAVENFORT A, HOSTON M, BOLTON C. Measurement of malondialdehyde as a marker of oxygen free radical production during renal allograft transplantation and the effect on early graft function. Clin Transpl 1995: 9: 171.
3. TAYLOR JE et al. Oxygen free radicals and platelet and granulocyte aggregability in renal transplant patients. Transplantation 1993: 55: 500.
4. WARD A, CLISSOLD SP. PTX - a review of its pharmacodynamic and pharmacokinetic properties, its therapeutic efficacy. Drugs 1987: 34: 50.
5. SULLIVAN GW, CARPER HT, NOVICK WJ, MANDELL GL. Inhibition of the inflammatory action of interleulin 1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun 1988: 56: 1722.
6. VAN LEENEN D et al. Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J. Immunol 1993: 151: 2318.
7. BERENS KL, LUKE DR. Pentoxifylline in isolated perfused rat kidney. Transplantation 1990: 49: 876.
8. NOWICK AC et al. Detrimental effect of cyclosporine on initial function of cadaver renal transplants following extended preservation. Transplantation 1986: 42: 154.
9. CARRIER M, PERRAULT LP, TRONC F, STEWART DI, PELLETIER CL. Pentoxifylline decreases cyclosporine-induced renal endothelin release and vasoconstriction. Ann Thorac Surg 1993: 55: 490.
10. MERKUS JWS, HOITSMA AJ, KOENE RAP. Detrimental effect of acute renal failure on the survival of renal allografts: influence of total ischaemia time and anastomosis time. Nephrol Dial Transpl 1991: 6: 881.
11. YOKOYAMA I, UCHIDA K, KOBAYASHI T, TOMINAGA Y, ORIHARA A, TAKAGI H. Effect of prolonged delayed graft function on long term graft outcome in cadaveric kidney transplantation. Clin Transpl 1994: 8: 101.
12. HOWARD RH et al. Increased incidence of rejection in patients with delayed graft function. Clin Transpl 1994: 8: 527-531
13. TROPPMANN C et al. Does acute tubular necrosis effect renal transplant outcome? The impact of rejection episodes. Transpl Proc 1993. 25: 905
14. WEISS SJ. Tissue destruction by neutrophil N Engl J Med 1989: 320: 365.
15. COTRAN R.S, POBER JS. Effects of cytokines on vascular endothelium: their role in vascular and immune injury. Kidney Int 1989: 35: 969.
16. HANCOCK WH et al. Cytokine, adhesion molecules, the pathogenesis of chronic rejection of rat renal allografts. Transplantation 1993: 56: 643.
17. STRIETER RM et al. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 1988: 155: 1230.
18. ZABEL P, SCHONHARTING MM, WOLTER DT, SHADE UF. Endotoxinemia and pentoxifylline. Lancet 1990: 6: 19.
19. ALEGRE ML et al. Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome. Transplantation 1991: 52: 674.
20. BACHMANN S et al. Protection by pentoxifylline against graft failure from storage injury after orthotopic rat liver transplantation with arterialization. Transpl Int 1992: 5: S 345.
21. KOZAKI K, EGAWA H, BERMUDES L. FEDUSKA NJ, SO S, ESQUIVEL CO. Pentoxifylline inhibits production of superoxide anion and tumor necrosis factor by kupffer cells in rat liver preservation. Transpl Proc 1993: 25: 3025.
22. PENG XX, CURRIN RT, THURMAN RG, LEMASTERS JJ. Protection by pentoxifylline against normothermic liver ischemia/reperfusion in rats. Transplantation 1995: 59: 1537.
23. BRUNNER LJ, VADIEI K, IYER LV, LUKE DR. Prevention of CsA induced nephrotoxicity with pentoxifylline. Ren Fail 1989: 11: 97.
24. SEGOLONI G, VERCELLONE A, MANES M, TETTA C, CAMUSSI G. Levels of tumor necrosis factor (TNF) in sera of renal allograft recipients. Clin Transpl 1991: 5: 102.
25. LAUGHLIN PJ et al. Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients. Transplantation 1991: 51: 1225.
26. AIKAWA A et al. TNF staining of graft biopsies in renal transplantation. Transplantation 1993: 56: 231.
27. VADIEI K, BRUNNER LJ, LUKE DR. Effects of pentoxifylline in experimental acute renal failure. Kidney Int 1989: 36: 466.